title: [Brucine inhibits the proliferation of human lung cancer cell line PC-9  via arresting cell cycle].
abstract: BACKGROUND
  It has been proven that Cyclin D1 and Cyclin E are the important positive regulators of cell cycle, they are closely related to the tumor proliferation. The aim of this study is to explore the relationship between Brucine and the proliferation in human lung cancer cell line PC-9, and the effect of it on the expression of Cyclin D1 and Cyclin E.
  
  
  METHODS
  PC-9 cells were divided to 4 groups: the normal control group, the DMSO control group (2‰), the 150 μM Brucine group, and the 300 μM Brucine group. The proliferation rate of PC-9 cells was determined by The CellTiter-Glo Luminescent Cell Viability Assay and Colony Formation assay. The change of cell cycle was detected by Flow cytome try. Expressions of cell cycle regulators Cyclin D1, Cyclin E mRNA were determined by qRT-PCR. Protein expression of cell cycle regulators Cyclin D1, Cyclin E were determined by Western blot.
  
  
  RESULTS
  Compared with the control, Brucine remarkably inhibited the proliferation of PC-9 cells in a dose- and time-dependent manner (P<0.01); Flow cytome try showed that Brucine blocked the cell cycle of PC-9 cells at G0/G1, and the differences were statistically significant (P<0.01); qRT-PCR showed that the expression of Cyclin D1, Cyclin E mRNA were down-regulated; Western blot showed that the protein expression of Cyclin D1, Cyclin E were down-regulated.
  
  
  CONCLUSIONS
  Brucine can inhibit the proliferation of human lung cancer cell line PC-9 mainly by blocking the cell cycle at G0/G1 via down-regulating the expression of Cyclin D1, Cyclin E.
authors.affiliation: Department of Chinese Medicine Tumor, the Affiliated Provincial Hospital of Anhui Medical University, Hefei 230001, China.
authors.forename: Miao
authors.initials: M
authors.lastname: Li
authors.affiliation: Department of Chinese Medicine Tumor, the Affiliated Provincial Hospital of Anhui Medical University, Hefei 230001, China.
authors.forename: Ping
authors.initials: P
authors.lastname: Li
authors.affiliation: Department of Chinese Medicine Tumor, the Affiliated Provincial Hospital of Anhui Medical University, Hefei 230001, China.
authors.forename: Mei
authors.initials: M
authors.lastname: Zhang
authors.affiliation: Department of Chinese Medicine Tumor, the Affiliated Provincial Hospital of Anhui Medical University, Hefei 230001, China.
authors.forename: Feng
authors.initials: F
authors.lastname: Ma
authors.affiliation: Department of Chinese Medicine Tumor, the Affiliated Provincial Hospital of Anhui Medical University, Hefei 230001, China.
authors.forename: Li
authors.initials: L
authors.lastname: Su
mesh_terms: D059447:Cell Cycle Checkpoints / Q000187:drug effects*; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D019938:Cyclin D1 / Q000235:genetics; D019927:Cyclin E / Q000235:genetics; D015536:Down-Regulation / Q000187:drug effects*; D004365:Drugs, Chinese Herbal / Q000494:pharmacology*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006131:Growth Inhibitors / Q000494:pharmacology*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology*; D013331:Strychnine / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D019927:Cyclin E; D004365:Drugs, Chinese Herbal; D006131:Growth Inhibitors; D019938:Cyclin D1; C083806:brucine; D013331:Strychnine